Our full CRO services and scientific approach are fully customized to suit each individual client's needs. Whether we are supporting government, NGOs or multinational public health organisations our teams are fully committed to saving lives and improving global health.
ICON IGP is the federal business unit of ICON plc, a top three global Contract Research Organization (CRO) with over 41,000 employees across 53 countries.
Our award-winning study execution capabilities and teams have led to the approval of 18 of the world’s top 20 best-selling drugs. As part of ICON we have the extended reach and resources to support government and non-governmental clients alike, and to carry out our mission of addressing global health concerns.
We have over 25 years’ experience in directly supporting multiple government agencies as well as being a trusted partner to both multinational public health organizations, and global Non-Government Organizations (NGOs)
Our experience extends across basic and applied research, infectious and neglected tropical diseases, oncology, CNS (Neurology, Pain research, Psychiatry, Traumatic Brain Injury), vaccines development and testing, cardiovascular and the response to biothreats.
Through our work in the military research corridor and alliances with world-class university researchers including Case Western, UNC, SUNY Upstate, we have established a strong network of consulting physicians and scientists with expertise in clinical research. This collaborative effort developed into our Medical Experts Office, which now offers consulting services for clinical trial design, regulatory strategy, and all aspects of medical product development. Additional strategic consulting services are offered by members with decades of experience in biotech and pharma, as well as government research centers.
Global clinical operations
ICON IGP provides the full portfolio of ICON services needed to conduct GCP-compliant clinical trials, including study design and protocol development, regulatory consultations and submissions, site selection, data management, clinical monitoring, quality assurance, medical writing, and staff training. Our clinical research and regulatory operations for Phase I-IV trials have historically been primarily focused in the US and Africa, but as part of ICON’s global footprint, we can manage operations for trials of any size, location, and indication.
Today, we have over 300 employees currently working in US Government laboratories, GMP manufacturing facilities, clinical trials centers, biomedical research laboratories, and regulatory affairs offices, all serving the mission of generating new and safe medical products
Strategic Solutions: Functional Services Provision
We provide global strategic resourcing and Functional Service Provision (FSP) services to our clients in the private and public sectors. Our team of over 14,000 people are working in partnership with more than 90 clients across 90 countries. We focus on using innnovative approaches to drive efficiencies and save costs with the ultimate goal of improving the business performance for better patient outcomes.